Literature DB >> 25245337

The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.

Z A Yegin1, Ö T İyidir2, C Demirtaş3, E Suyanı4, İ Yetkin2, H Paşaoğlu3, Ç İlhan4, G T Sucak4.   

Abstract

PURPOSE: Metabolic syndrome (MetS) is considered as a proinflammatory and prothrombotic state with atherogenic risk factors including dyslipidemia, obesity and glucose intolerance. Oxidative stress is a unifying basis of several disorders including diabetes mellitus (DM) and MetS. We therefore designed this cross-sectional study to investigate the potential interaction among iron metabolism, inflammation and endothelial plexus in MetS and DM patients.
METHODS: A total of 62 patients [median age 54 (23-76) years; male/female 16/46] and 18 healthy controls [median age 38 (30-64) years; male/female 6/12] were included in the study. Patient population was classified as MetS (n = 30) and DM (n = 32).
RESULTS: Leukocyte count (p = 0.002) and osteopontin (OPN) levels (p = 0.008) were significantly higher, while C-reactive protein (CRP) (p = 0.056) and IL-6 (p = 0.059) represented a relative increase in the patient group. Leptin, endothelin 1 (ET1), hepcidin, nitric oxide synthase (NOS), erythrocyte sedimentation rate (ESR), iron, transferrin saturation (TS) and ferritin levels were not significantly different between the patient and control groups. Endothelin 1 was found to be higher in the DM group compared to MetS group (p = 0.15, p = 0.049). Leukocyte count, leptin, hepcidin, OPN, NOS, IL-6, ESR, CRP, iron, TS and ferritin levels were not different between DM and MetS groups. A positive correlation was demonstrated between leptin and OPN (p = 0.001, r = 0.360), ferritin and hepcidin (p < 0.01, r = 0.633), IL-6 and CRP (p = 0.023, r = 0.319), leptin and NOS (p = 0.005, r = 0.309) and OPN and NOS (p < 0.001, r = 0.803). There was a negative correlation between hepcidin and NOS (p = 0.009, r = -0.289). When the study cohort was divided into two particular groups based on median ferritin and hepcidin levels, hepcidin (p = 0.002), ALT (p = 0.001) and LDL (p = 0.049) levels were higher in the high-ferritin group. Nitric oxide synthase levels (p = 0.033) were lower, whereas ferritin levels (p = 0.004) were higher in the high-hepcidin group.
CONCLUSION: Mechanisms involved in the vicious circle of MetS including inflammation, endothelial vasculature and iron metabolism remain to be elucidated. The role of iron metabolism in this complex interaction should be confirmed with further studies.

Entities:  

Keywords:  Diabetes mellitus; Ferritin; Hepcidin; Iron overload; Metabolic syndrome; Osteopontin

Mesh:

Substances:

Year:  2014        PMID: 25245337     DOI: 10.1007/s40618-014-0174-6

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

1.  Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations.

Authors:  Luca Valenti; Paola Dongiovanni; Benedetta Maria Motta; Dorine W Swinkels; Paola Bonara; Raffaela Rametta; Larry Burdick; Cecelia Frugoni; Anna Ludovica Fracanzani; Silvia Fargion
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-12-23       Impact factor: 8.311

2.  Prevalence of body iron excess in the metabolic syndrome.

Authors:  Claudia Bozzini; Domenico Girelli; Oliviero Olivieri; Nicola Martinelli; Antonella Bassi; Giovanna De Matteis; Ilaria Tenuti; Valentina Lotto; Simonetta Friso; Francesca Pizzolo; Roberto Corrocher
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

Review 3.  Adipocytokines - novel link between inflammation and vascular function?

Authors:  T J Guzik; D Mangalat; R Korbut
Journal:  J Physiol Pharmacol       Date:  2006-12       Impact factor: 3.011

4.  Men with hyperferritinemia and diabetes in the Mediterranean area do not have a higher iron overload than those without diabetes.

Authors:  Núria Freixenet; Carme Vilardell; Gemma Llauradó; Olga Giménez-Palop; Eugenio Berlanga; Cristina Gutiérrez; Assumpta Caixàs; Joan Vendrell; José Miguel González-Clemente
Journal:  Diabetes Res Clin Pract       Date:  2010-11-04       Impact factor: 5.602

5.  Systemic blood osteopontin, endostatin, and E-selectin concentrations after vertical banding surgery in severely obese adults.

Authors:  Jan Komorowski; Joanna Jankiewicz-Wika; Krzysztof Kolomecki; Jacek Cywinski; Katarzyna Piestrzeniewicz; Jacek Swiętoslawski; Henryk Stepien
Journal:  Cytokine       Date:  2011-04-12       Impact factor: 3.861

6.  Study of iron metabolism disturbances in an animal model of insulin resistance.

Authors:  Guillaume Le Guenno; Emilie Chanséaume; Marc Ruivard; Béatrice Morio; Andrzej Mazur
Journal:  Diabetes Res Clin Pract       Date:  2007-03-09       Impact factor: 5.602

Review 7.  Human obesity and endothelium-dependent responsiveness.

Authors:  Umberto Campia; Manfredi Tesauro; Carmine Cardillo
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

8.  Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome.

Authors:  Alberto Piperno; Anna Vergani; Alessandra Salvioni; Paola Trombini; Mauro Viganò; Alessia Riva; Adele Zoppo; Giuseppe Boari; Giuseppe Mancia
Journal:  Liver Int       Date:  2004-10       Impact factor: 5.828

9.  Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly chinese.

Authors:  Liang Sun; Oscar H Franco; Frank B Hu; Lu Cai; Zhijie Yu; Huaixing Li; Xingwang Ye; Qibin Qi; Jing Wang; An Pan; Yong Liu; Xu Lin
Journal:  J Clin Endocrinol Metab       Date:  2008-09-16       Impact factor: 5.958

10.  Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study.

Authors:  Nicola Martinelli; Michela Traglia; Natascia Campostrini; Ginevra Biino; Michela Corbella; Cinzia Sala; Fabiana Busti; Corrado Masciullo; Daniele Manna; Sara Previtali; Annalisa Castagna; Giorgio Pistis; Oliviero Olivieri; Daniela Toniolo; Clara Camaschella; Domenico Girelli
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

View more
  5 in total

1.  Association between serum ferritin levels and metabolic syndrome: an updated meta-analysis.

Authors:  Yuelong Jin; Lianping He; Yi Chen; Yun Fang; Yingshui Yao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Is peritoneal dialysis causing a measurable burden of inflammatory and endothelial injury on top of metabolic syndrome?

Authors:  M Miler; N Nikolac; D Segulja; S Kackov Maslac; I Celap; K Altabas; S Sefer; A M Simundic
Journal:  J Endocrinol Invest       Date:  2016-09-06       Impact factor: 4.256

3.  Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome.

Authors:  T Suzuki; Z Zeng; B Zhao; Z Wei; M Tanabe; T Shimbo; H Kajio; N Kato; M Naruse
Journal:  J Endocrinol Invest       Date:  2016-08-29       Impact factor: 4.256

4.  Biliary tract external drainage increases the expression levels of heme oxygenase-1 in rat livers.

Authors:  Lu Wang; Bing Zhao; Ying Chen; Li Ma; Er-Zhen Chen; En-Qiang Mao
Journal:  Eur J Med Res       Date:  2015-07-22       Impact factor: 2.175

5.  GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance.

Authors:  Mehmet Muhittin Yalcin; Alev Eroglu Altinova; Mujde Akturk; Ozlem Gulbahar; Emre Arslan; Damla Ors Sendogan; Ilhan Yetkin; Fusun Balos Toruner
Journal:  J Diabetes Res       Date:  2016-08-25       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.